China Resources Pharmaceutical owns China Resources Pharmaceutical Industry Development (Beijing) Co., Ltd., Innovation Incubation Division, China Resources Pharmaceutical Business Group Co., Ltd., China Resources Sanjiu Pharmaceutical Co., Ltd., China Resources Shuanghe Pharmaceutical Co., Ltd., Shandong Dong 'e Ejiao Co., Ltd., China Resources Secco Pharmaceutical Co., Ltd., China Resources Zizhu Pharmaceutical Co., Ltd., Anhui Huayuan Pharmaceutical Co., Ltd., China Resources Pien Tze Huang Pharmaceutical Co., Ltd. and other enterprises. Among them, China Resources Sanjiu (000999), China Resources Shuanghe (600062) and Dong 'e Ejiao (000423) are domestic A-share listed companies. In 20 12, China Resources Pharmaceutical achieved a turnover of HK$ 98.6 billion, an operating profit of HK$ 60/Kloc-0.50 billion and total assets of HK$ 85.6 billion, ranking among the top three in the pharmaceutical industry in China.